FIX Down 14% in a Week, But the Borrow Market Doesn't Care

Comfort Systems USA dropped 14.1% over the past week to close at $1,397.09, a steeper fall than most of its sector but one that has drawn almost no response from the short-selling community.

The sell-off landed at the heavy end of a broad sector repricing rather than in isolation. EMCOR Group fell 9.5% on the week, Quanta Services lost 13.5%, and IES Holdings shed 13.8%. FIX's 14.1% decline is in the same neighbourhood, suggesting macro or sector-level pressure rather than stock-specific disappointment. What makes the pattern notable is where short sellers have not gone. Short interest remains at 2.4% of the free float, barely changed over the week, and the borrow market is entirely unconstrained: 34.8 million shares are available to lend, a ratio so loose the availability reading sits at the platform ceiling. Cost to borrow is just 0.33%, down nearly 19% on the week. None of the usual mechanics of a stock under genuine short pressure are present.

Options positioning has actually moved in the opposite direction to what the price action might suggest. The put/call ratio dropped to 1.15, roughly 1.7 standard deviations below its 20-day average of 1.25, and has been falling steadily since late September when it sat above 1.35. That means call demand has risen relative to puts even as the stock sold off. It is the lowest PCR reading of the past year, and it stands in direct contrast to the price decline. Whether that reflects conviction buyers using the dip or simply expiring hedges rolling off, the options market is not treating this as a stock in distress.

The Street remains firmly positive ahead of tomorrow's Q3 report. The analyst consensus carries a mean price target of $2,163, implying roughly 55% upside from current levels. Keybanc raised its target to $2,125 on October 15, maintaining an Overweight rating. Earlier in the cycle, Goldman Sachs initiated at Buy with a $2,159 target, UBS raised its target to $2,225, and Oppenheimer started coverage at Outperform with a $2,200 target. Every recent move has been in one direction. The valuation has compressed sharply with the price: the P/E multiple has fallen more than 4 points over the past 30 days to around 24 times, and EV/EBITDA has dropped more than a full turn to 17.4 times. Factor scores reflect the compression, with the earnings quality picture still solid (EPS surprise in the 79th percentile, 90-day EPS momentum in the 87th percentile) but the forward earnings growth rank a weak 18th percentile, which is the number bears point to when arguing the hyperscaler-driven growth story has limited runway.

The debate is a concentration argument. The bull case rests on a $14.1 billion backlog, $1.8 billion of net cash, peer-leading margins, and a modular manufacturing platform that has grown at close to a 50% compound annual rate since 2021, with capacity set to reach 5 million square feet by mid-2027. Bears counter that the capacity expansion is almost entirely driven by existing hyperscaler commitments rather than broad demand, leaving the growth profile hostage to a small number of customers. Broader non-residential construction spending remains weak, down around 5% year on year. Insider activity adds a note of caution: the CEO sold $25.8 million of stock in late August, the CFO sold $4.7 million in mid-August, and a director sold across multiple tranches totalling over $12 million, none of it under a pre-arranged 10b5-1 plan. Those trades happened at prices between $1,608 and $1,860, well above where the stock now trades.

The company reports after the close tomorrow, October 22. The last two prints both produced negative one-day moves of 3.2% and 5.5% respectively, and five-day returns were similarly soft. With the stock already down 15% over the past month, the question for the print is less about whether growth continues and more about whether management can offer enough clarity on the hyperscaler pipeline concentration to reset confidence in the backlog quality.